CL - Oral Care Giant Colgate-Palmolive Plans High Brand Investment In 2024 After Beating Q4 Earnings With Solid Margins | Benzinga
Colgate-Palmolive Company (NYSE:CL) reported fourth-quarter FY23 sales growth of 7% year-on-year to $4.95 billion, beating the analyst consensus estimate of $4.89 billion.
Total Oral, Personal, and Home Care net sales increased by 7.5% to $3.84 billion.
Base Business (non-GAAP) EPS of $0.87 beat the analyst consensus of $0.80.
GAAP Gross profit margin and Base Business Gross profit margin both increased 400 basis points to 59.6%
The company said that net cash provided by operations was ...